| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.081 | 42.283 | 73.914 | 86.739 | 163.357 |
| Total Income - EUR | - | - | - | - | - | 1.081 | 42.288 | 75.023 | 93.957 | 165.885 |
| Total Expenses - EUR | - | - | - | - | - | 1.763 | 5.382 | 7.564 | 18.150 | 29.633 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -682 | 36.906 | 67.459 | 75.807 | 136.252 |
| Net Profit/Loss - EUR | - | - | - | - | - | -714 | 35.663 | 65.867 | 75.008 | 131.525 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Dr Yaşar Visioon S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 59.526 |
| Current Assets | - | - | - | - | - | 437 | 36.295 | 101.206 | 180.368 | 115.659 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 289 | 4.011 | 7.740 | 15.679 | 106.238 |
| Cash | - | - | - | - | - | 148 | 32.284 | 93.466 | 164.689 | 9.421 |
| Shareholders Funds | - | - | - | - | - | -673 | 35.005 | 100.980 | 175.683 | 131.573 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.258 | 1.582 | 724 | 5.141 | 45.599 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Yaşar Visioon S.r.l.